ValGenesis, Inc. today announced Fort Dodge Animal Health, a division of Wyeth (NYSE: WYE - News), has implemented ValGenesis software to automate, manage and track its validation process


Fremont, CA  October 26 ,2006,

ValGenesis, Inc. welcomed the opportunity to work with Fort Dodge Animal Health to implement its innovative software solution, which is an Enterprise Validation Management System (EVMS). In its search for a validation management system, Fort Dodge identified the need for a cost effective and more time efficient system, as well as one that would remove risks associated with paper-based reviews and approval processes. ValGenesis offers significant improvement in efficiencies, a reduction in cycle times for the validation process, ensures regulatory compliance, and provides a broad view of a company\'s validation status to identify bottlenecks, which, when resolved, can expedite the validation process. ValGenesis is an out-of-the-box solution that requires less overall implementation and validation time, and allows the information technology and validation experts at Fort Dodge to manage other projects simultaneously.

"Using a current paper-based validation process, tracking the validation status of any system is time consuming and very often submerged in a sea of paper," says Dr. Siva Samy, ValGenesis\' Chief Product Strategist. "It is estimated the validation process in a paper-based environment, including protocol development, execution, incident management and the review of related activities, requires up to 70 percent more resources, which impacts revenue- producing manufacturing activities. "ValGenesis is an end-to-end validation management system designed to automate, manage and track the corporate validation process. Our unique technology automates the corporate validation process, removes potentially time-consuming tasks, and provides consistency and compliance in the corporate validation process."

About ValGenesis

ValGenesis is an innovative software platform designed to provide the foundation for compliance-based validation activities in life science companies. ValGenesis is the first Enterprise application to automate the corporate validation life cycle and to track the Validation Inventory. Through an industry peer review committee, The Parenteral Drug Association (PDA) recognized ValGenesis by awarding it the very prestigious New Innovative Technology award for the year 2005. ValGenesis is designed to be fully compliant with US FDA 21 CFR Part 11 compliance requirements. For more information, visit ValGenesis\' Web site at www.valgenesis.com .